402 results match your criteria: "Institute for Safe Medication Practices[Affiliation]"
Home Healthc Now
June 2019
Ann Shastay, MSN, RN, AOCN, is Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
Pain Med
September 2019
Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Objective: To determine trends in opioid prescribing for home use after pediatric outpatient surgery.
Design: Retrospective analysis of a de-identified database.
Setting: Multispecialty children's hospital and freestanding surgery centers.
Home Healthc Now
April 2019
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
CMAJ Open
December 2018
Leslie Dan Faculty of Pharmacy (Boucher, Ho), University of Toronto; Institute for Safe Medication Practices Canada (Boucher, Ho), Toronto, Ont.; James L. Winkle College of Pharmacy (MacKinnon), University of Cincinnati, Cincinnati, OH; Gerald Schwartz School of Business (Boyle), St. Francis Xavier University, Antigonish, NS; IWK Health Centre (Bishop); Rowe School of Business (Gonzalez, Barker), and Department of Business and Social Science (Hartt), Dalhousie University, Halifax, NS.
Background: Quality-related events are defined as medication errors that reach the patient (e.g., incorrect drug, dose and quantity), in addition to medication errors that are intercepted before dispensing (i.
View Article and Find Full Text PDFAnesth Analg
January 2019
Northeastern University, Boston, Massachusetts, Scott & White Temple Medical Center, Temple, Texas Parkdale Center for Professionals, Chesterton, Indiana Preferred Physicians Medical, Overland Park, Kansas The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, Institute for Safe Medication Practices, Horsham, Pennsylvania.
Br J Anaesth
December 2018
Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Institute for Safe Medication Practices, Horsham, PA, USA.
JAMA Intern Med
November 2018
Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Importance: A critical question in health care is the extent of scientific evidence that should be required to establish that a new therapeutic agent has benefits that outweigh its risks. Estimating the costs of this evidence of efficacy provides an important perspective.
Objective: To estimate costs and assess scientific characteristics of pivotal efficacy trials that supported the approval of new therapeutic agents by the US Food and Drug Administration (FDA) from 2015 to 2016.
Can Pharm J (Ott)
May 2018
Cancer Care Ontario (Vu), Toronto.
J Biomed Inform
October 2018
National Center for Human Factors in Healthcare, MedStar Health, 3007 Tilden St. NW, Suite 7L, Washington, D.C. 20008, USA; Georgetown University School of Medicine, 3800 Reservoir Rd NW, Washington, DC 20007, USA.
Objective: The objective of this paper was to identify health information technology (HIT) related events from patient safety event (PSE) report free-text descriptions. A difference-based scoring approach was used to prioritize and select model features. A feature-constraint model was developed and evaluated to support the analysis of PSE reports.
View Article and Find Full Text PDFJ Oncol Pharm Pract
April 2019
4 Canadian Association of Provincial Cancer Agencies (CAPCA), Toronto, Ontario, Canada.
Purpose: To create a set of consensus-based and evidence-informed recommendations to provide guidance around the safe dispensing and handling of oral anti-cancer drugs in low-volume settings unique to the community pharmacy setting.
Methods: A review of published and grey literature (published in non-commercial domains such as national organizations and associations) documents and nine key informant interviews were conducted and a modified Delphi approach was taken to achieve consensus. The final list of 47 candidate recommendations was reviewed by a task force and validated by multi-disciplinary stakeholders.
Home Healthc Now
July 2019
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
A recent string of errors associated with tacrolimus, an immunosuppressant used primarily to prevent rejection in transplant recipients, prompted ISMP to review the literature and analyze related events reported to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and the ISMP National Medication Errors Reporting Program (MERP). We found that tacrolimus has been involved in many reported errors during the past decade that have been caused by a wide variety of factors, the most common of which are described below.
View Article and Find Full Text PDFHosp Pharm
July 2018
Institute for Safe Medication Practices, Horsham, PA, USA.
JAMA Intern Med
September 2018
Risk Sciences International, Ottawa, Ontario, Canada.
This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
View Article and Find Full Text PDFHome Healthc Now
November 2018
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
JAMIA Open
October 2018
Center for Communication and Health, Department of Communication Studies, Northwestern University, Chicago, Illinois, USA.
Objective: Hospitalized patients often receive opioids. There is a lack of consensus regarding evidence-based guidelines or training programs for effective management of pain in the hospital. We investigated the viability of using an Internet-based opioid dosing simulator to teach residents appropriate use of opioids to treat and manage acute pain.
View Article and Find Full Text PDFHome Healthc Now
November 2018
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
Hosp Pharm
April 2018
Institute for Safe Medication Practices, Horsham, PA, USA.
Home Healthc Now
November 2018
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
Br J Anaesth
March 2018
Institute for Safe Medication Practices, Horsham, PA, USA; Department of Anaesthesiology and Critical Care, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address:
Appl Clin Inform
February 2017
National Center for Human Factors in Healthcare, MedStar Health, Washington, DC
Background: With the widespread use of electronic health records (EHRs) for many clinical tasks, interoperability with other health information technology (health IT) is critical for the effective delivery of care. While it is generally recognized that poor interoperability negatively impacts patient care, little is known about the specific patient safety implications. Understanding the patient safety implications will help prioritize interoperability efforts around architectures and standards.
View Article and Find Full Text PDFHome Healthc Now
November 2018
Ann Shastay, MSN, RN, AOCN, is the Managing Editor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
Hosp Pharm
July 2017
Temple University School of Pharmacy, Philadelphia, PA, USA.
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr.
View Article and Find Full Text PDFHosp Pharm
June 2017
Institute for Safe Medication Practices, Horsham, PA, USA.
These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided.
View Article and Find Full Text PDF